General Law committee advances broad cannabis, hemp and tobacco regulation bill after extended debate

The General Law Committee voted to send HB 7178 (LCO 6831), an omnibus bill on cannabis, hemp and tobacco regulation, to the House floor after extended debate on March 24.

The bill would permit manufacturers to produce infused beverages for sale in states where higher THC levels are allowed while keeping Connecticut’s in‑state sale limits unchanged, expand rules for multi‑site and outdoor cultivation under existing square‑footage caps, relax certain packaging color requirements, shorten the period for equity‑partner ownership limits from seven years to three years with Social Equity Council approval for increases, and create a laboratory testing task force to study cannabis product testing standards. Senator Maroney, who presented the bill, said, “We are not changing what’s allowed for sale in the state of Connecticut. What we are saying is if your business wants to manufacture those items for sale in states where it is allowed, you’re allowed to do that.”

Why it matters: HB 7178 tries to balance two long‑running policy goals — preventing youth‑directed marketing and unsafe products from entering the state’s retail market, while easing regulatory burdens that committee members and industry witnesses said have harmed licensed hemp farmers and small cultivators. The bill seeks to preserve the state’s consumer protections for on‑sale products while creating limited pathways for production and interstate commerce.

Most important provisions - Out‑of‑state manufacture for sale elsewhere: The bill allows in‑state manufacturers to produce infused beverages with THC content greater than Connecticut’s in‑state retail cap for shipment to states that allow higher limits; it does not change what can be sold in Connecticut. (Sponsor presentation and Q&A) - Outdoor and multi‑site cultivation: Licensed cultivators may operate multiple cultivation locations, including outdoor sites, as long as they remain within their licensed total square footage (examples discussed referenced the 25,000 sq. ft. envelope). Committee members asked whether hemp farms contracted to grow cannabis would need separate local approvals; the chair said further review was required. (Q&A) - High‑THC hemp and interstate sales: The bill includes language distinguishing “high THC hemp” (defined in committee discussion as products exceeding certain milligram or dry‑weight THC thresholds) and allows manufacture for out‑of‑state sale where permitted under federal or other states’ law. Several members said this raised enforcement and interstate‑commerce questions. (Questions by Senator Ciccarella and response by Senator Maroney) - Packaging and marketing limits: The bill clarifies and tightens prohibitions on products and packaging that might appeal to children (facsimiles of snacks, cartoons, etc.) while allowing greater use of color and brand identifiers for adult products. (Sponsor presentation) - Social equity and ownership changes: The statutory period during which an equity joint venture is capped at 50% would move from seven years to three years; increases in ownership above thresholds would require approval by the Social Equity Council. (Sponsor presentation) - Internal theft/loss investigations: The bill permits cannabis establishments to conduct internal investigations for suspected theft or loss up to specified thresholds (the bill text referenced $500) before or instead of immediate DCP action, subject to applicable laws. Committee members requested additional guidelines for such internal investigations. (Q&A) - Laboratory testing task force: The measure would create a task force to study laboratory testing standards (for example, whether to require final‑form testing rather than intermediate bulk testing) and recommend scientific standards. Senator Maroney said the science is complex and best studied by a task force.

Key points of contention and committee questions Committee members repeatedly raised concerns about the interplay between hemp and cannabis licensing, local zoning, and whether contracting hemp growers could lawfully switch to growing cannabis without new local approvals. Senator Maroney said he would investigate zoning and licensing ambiguities. Senator Ciccarella and others pushed back on provisions that could be read as allowing high‑THC hemp production that functionally resembles marijuana; those members expressed concern about public‑safety and enforcement implications. Representative Vitagliano and others sought clearer testing and accreditation standards for laboratories.

Votes and next steps The committee voted to send HB 7178 (LCO 6831) to the floor (motion carried). Sponsors and members said they expect continued negotiations on technical clarifications — especially the hemp/cannabis interface, testing accreditation, and local approval questions — before the bill reaches final floor action.

Quote “We are not changing what’s allowed for sale in the state of Connecticut,” Senator Maroney said. “What we are saying is if your business wants to manufacture those items for sale in states where it is allowed, you’re allowed to do that.”

What remains unresolved Committee members asked staff and the Department of Consumer Protection to clarify: whether hemp farms that begin producing cannabis would need new zoning or local approvals; who accredits and audits laboratories for the new testing standards; and specific rules or approvals for packaging/logo reviews to ensure products do not appeal to children. Sponsors committed to further drafting and stakeholder meetings before floor debate.

Ending Committee members said they will continue negotiating technical fixes and clarifications in the coming weeks while the bill proceeds to the House floor.